99mTC-EDDA-HYNIC-TOC versus 111In-DTPA-octreotide para diagnóstico e estadiamento de tumores neuroendócrinos

13/09/2018

Abstracts, Publications, Publications Gastro-Intestinal

XXXII Congresso Brasileiro de Medicina Nuclear 2018
Cristina Maria Moriguchi Jeckel, Rafael Ribeiro Madke, Graciane Radaelli, Eduardo Herz Berdichevski, Eduardo Vilas, Samuel Greggio, Gianina Teribele Venturin, Carlos Henrique Barrios, Facundo Zaffaroni, Gustavo Werutsky, Jaderson Costa da Costa

99mTC-EDDA-HYNIC-TOC versus 111In-DTPA-octreotide para diagnóstico e estadiamento de tumores neuroendócrinos

Send us a message

Cura Project

99mTC-EDDA-HYNIC-TOC versus 111In-DTPA-octreotide para diagnóstico e estadiamento de tumores neuroendócrinos

Related Posts

Current status of clinical and pathological characteristics of breast cancer patients in Brazil: results of the AMAZONA III study (GBECAM 0115).

Advanced stage at diagnosis and worse clinicopathologic features in young woman with breast cancer. a sub-analysis of Brazilian population through the AMAZONA III study (GBECAM 0115).

The AMAZONA project: retrospective cohort study describing breast cancer patients’ characteristics and survival in Brazil.

Quality of life in newly diagnosed patients with cervical cancer in Brazil: results of EVITA study (EVA/LACOG 0215).